Overview

EPIC(Effect of PhosLo on Phosphorus Levels in Chronic Kidney Disease)

Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if calcium acetate (PhosLo) can control serum phosphorus in pre-dialysis patients with moderate to severe impairment of kidney function.
Phase:
Phase 3
Details
Lead Sponsor:
Nabi Biopharmaceuticals
Treatments:
Calcium
Calcium acetate